MEDFORD, N.Y.--(BUSINESS WIRE)--March 27, 2006--Chembio Diagnostics, Inc.'s (OTCBB:CEMI) HIV 1/2 STAT-PAK(TM) and HIV 1/2 STAT-PAK(TM) Dipstick tests have been evaluated and recommended for use in Kenya. Both tests were evaluated by the National AIDS/STD Control Programme of the Kenyan Ministry of Health and met their sensitivity and specificity requirements. The approval allows Chembio to begin selling its products in the country.
